Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Implementation of pharmacogenomics: Where are we now?
Samantha Medwid1,2,3, Richard B Kim1,2,3
1Department of Medicine, University of Western Ontario, London, Ontario, Canada.
Pharmacogenomics (PGx) use is increasing due to improved testing. This review discusses PGx implementation, challenges like diversity, and future directions, using DPYD genotyping as a case study.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacology
- Genetics
Background:
- Pharmacogenomics (PGx) research has a long history, focusing on genetic variations influencing drug response.
- Advances in cost and speed have accelerated the clinical adoption of PGx testing.
- Despite progress, widespread clinical implementation of PGx faces significant challenges.
Purpose of the Study:
- To review current models and evaluation methods for PGx delivery.
- To discuss clinically relevant PGx tests and associated medications.
- To highlight challenges and future directions in PGx implementation.
Main Methods:
- Review of current PGx delivery models and evaluation methodologies.
- Discussion of clinically actionable PGx tests and medications.
- Case study: Implementation of pre-emptive DPYD genotyping for fluoropyrimidine therapy in Ontario, Canada.
Main Results:
- PGx testing is gaining momentum in clinical settings due to improved accessibility.
- DPYD genotyping for fluoropyrimidine users is presented as an example of actionable PGx.
- Challenges include limited diversity in PGx studies and general adoption barriers.
Conclusions:
- Pharmacogenomics holds significant potential to become a standard of care.
- Addressing diversity and implementation barriers is crucial for broader PGx adoption.
- Future research should focus on new clinical targets, methodologies, and analysis approaches.
Related Concept Videos
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Analysis of Population Pharmacokinetic Data
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacokinetics: Overview
Factors Affecting Drug Response: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

